An experimental drug from NewAmsterdam Pharma has shown it may protect heart health in a Phase 3 study, a finding Wall Street ...
Today, Unite Genomics announced a new partnership with a top 10 pharmaceutical company, adding to its growing list of pharma customers. The collaboration will empower Psoriasis patients to better ...
The company's ‘Zeta” platform encompasses the following oncological drug candidates ZetaMet™ (Zeta-BC-003), ZetaMet-P™ (Zeta-PC-004) and ZetaMAST™ (Zeta-MBC-005). To learn more, visit www.zetagen.com ...
The Almac Group has today announced the release of its 2024 Sustainability Report which outlines Almac’s ongoing commitment to their people, the planet and the communities where the Group operates, ...
A lengthy treatment process, coupled with weighty risks for recipients to consider, has resulted in plodding adoption of ...
Clinical services organizations help pharmaceutical manufacturers manage growing regulatory complexities, high development ...
Despite the disease’s prevalence, endometriosis remains misunderstood, and research into drugs that might treat it draws scant funding — problems that have deep roots.
The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...
At the center of a new licensing deal is an experimental medicine, PTC518, which is currently being tested in a roughly ...
A Johns Hopkins surgeon, Marty Makary also serves as a board member or adviser to several companies, including one that ...
Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...
The two partners disclosed study results supporting an approval application for their drug dato-dxd. Elsewhere, Agenus cut ...